Lensar (LNSR) Net Shares Issued and Repurchased (2019 - 2025)
Lensar's (LNSR) quarterly Net Shares Issued and Repurchased came in at $23000.0 in Q4 2025, down 85.8% year-over-year from $162000.0 in Q4 2024, and up 228.57% quarter-over-quarter from $7000.0 in Q1 2025.
Analysis
Lensar (LNSR) Net Shares Issued and Repurchased (2019 - 2025) Analysis & Trends
Lensar (LNSR) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $23000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased fell 85.8% year-over-year to $23000.0 in Q4 2025; TTM through Dec 2025 was $23000.0, a 85.8% decrease from a year earlier, with the FY2025 full-year figure at $23000.0, down 85.8% from the prior year.
- Net Shares Issued and Repurchased was $23000.0 for Q4 2025 at Lensar, up from $7000.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $166.4 million in Q1 2021 and troughed at $7000.0 in Q1 2025.
- A 5-year average of $17.0 million and a median of $421500.0 in 2022 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased plunged 99.71% in 2022 and jumped 40.88% in 2023, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $674000.0 in 2021, then dropped by 12.17% to $592000.0 in 2022, then jumped by 40.88% to $834000.0 in 2023, then slumped by 80.58% to $162000.0 in 2024, then tumbled by 85.8% to $23000.0 in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $23000.0 (Q4 2025), $7000.0 (Q1 2025), and $162000.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.22 Bn | 178.62 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.47 Bn | 119.26 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.41 Bn | 109.59 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.06 Bn | 101.58 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.48 Bn | 65.94 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.33 Bn | 30.38 Bn | 830.00 Mn | - |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn | - |
| 10 | Lensar | 102.19 Mn | 88.62 Mn | 9.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 23,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 162,000.00 |
| Mar 31, 2024 | 108,000.00 |
| Dec 31, 2023 | 834,000.00 |
| Mar 31, 2023 | 367,000.00 |
| Dec 31, 2022 | 592,000.00 |
| Mar 31, 2022 | 476,000.00 |
| Dec 31, 2021 | 674,000.00 |
| Mar 31, 2021 | 166.40 Mn |
| Dec 31, 2019 | 1,000.00 |